Pulmonary embolus (PE) is the third most common cause of cardiovascular death with more
than 600,000 cases occurring in the USA per year. About 45% of patients with acute PE will …

In the USA, and worldwide, acute venous thromboembolism remains a major cause of
morbidity and mortality. It is estimated that 600,000 episodes of acute pulmonary embolism …

OBJECTIVE. The utility of CT findings in predicting long-term mortality in patients with acute
pulmonary embolism (PE) is unknown. The purpose of this study is to retrospectively …

Background In patients with acute pulmonary embolism (PE), rapid and accurate risk
assessment is paramount in selecting the appropriate treatment strategy. The prognostic …

Background New diagnosis, risk stratification, and treatment strategies became recently
available for patients with acute pulmonary embolism (PE) leading to changes in clinical …

Background No published data have systematically documented pulmonary artery pressure
over an intermediate time period after submassive pulmonary embolism (PE). The aim of this …

An acute pulmonary embolism (aPE) is characterised by occlusion of one or more
pulmonary arteries. Physiological disturbance may be minimal, but often cardiac output …

Background Morbidity and mortality for acute pulmonary embolism (PE) remain high.
Therapies such as catheter-directed thrombolysis may improve outcomes, but these are …

The eVects of an embolus depend on the extent to which it obstructs the pulmonary
circulation, the duration over which that obstruction accumulates, and the pre-existing state …

Background The current diagnostic delay of chronic thromboembolic pulmonary
hypertension (CTEPH) after pulmonary embolism (PE) is unacceptably long, causing loss of …